Key result
Takotsubo therapies like extracorporeal support and beta-blockade may improve cardiac donor care after brain death.
Why the study?
Takotsubo cardiomyopathy shares histopathological and clinical similarities with cardiac changes after brain death, suggesting potential relevance to adult donor care.
Treatment strategies for Takotsubo cardiomyopathy, such as non-beta-receptor stimulating medications and preemptive beta or calcium channel blockade, may be relevant for managing cardiac changes in adult donors after brain death.
May inform donor heart management strategies; leaves open whether Takotsubo-inspired therapies improve transplant outcomes.
Takotsubo cardiomyopathy, the syndrome caused by an extreme release and circulation of catecholamines, shares several histopathological and clinical similarities with cardiac changes after brain death noted in animal investigations and human observation. Overwhelming stimulation of myocardial inotropic β receptors may alter their responsiveness and induce other biochemical processes, producing reduced cardiac contractility. Treatment methods in Takotsubo cardiomyopathy that use extracorporeal circulatory support and medications that do not rely on β-receptor stimulation and preemptive blockade of β receptors or calcium channels before brain death may be relevant to donor care.
No takes yet. Share an insight, caveat, or question.
Powner et al. (2011) conducted a review in Takotsubo cardiomyopathy. Takotsubo cardiomyopathy shares similarities with cardiac changes after brain death, suggesting that treatments like extracorporeal support and preemptive beta-blockade may be relevant to donor care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: